A detailed history of Park Place Capital Corp transactions in Dexcom Inc stock. As of the latest transaction made, Park Place Capital Corp holds 24 shares of DXCM stock, worth $1,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 24 -0.0%
Holding current value
$1,821
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$110.31 - $140.45 $23,826 - $30,337
-216 Reduced 90.0%
24 $2,000
Q4 2023

Jan 24, 2024

SELL
$75.49 - $124.16 $108,252 - $178,045
-1,434 Reduced 85.66%
240 $29,000
Q3 2023

Oct 17, 2023

SELL
$86.06 - $137.93 $23,408 - $37,516
-272 Reduced 13.98%
1,674 $156,000
Q2 2023

Aug 04, 2023

BUY
$112.47 - $130.98 $3,374 - $3,929
30 Added 1.57%
1,946 $250,000
Q1 2023

May 02, 2023

BUY
$104.0 - $122.92 $208 - $245
2 Added 0.1%
1,916 $222,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $162,651 - $234,790
1,914 New
1,914 $217,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.